EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Strain-specific persistence of Burkholderia cenocepacia in the C3HeB/FeJ mouse model of pulmonary infection

Ziting Chen, Mariana Romero-Gonzalez, Andrea Maser, Ruisi Leng, Lindsay J Caverly, Marc Hershenson, Ashlee D Brunaugh

Journal of Medical Microbiology · 09.04.2026 · 75 (4)

DOI: 10.1099/jmm.0.002153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Microbiology, erschienen am 09.04.2026. Verfasst von Ziting Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, 48109, USA. Hauptthemen laut MEDLINE: Burkholderia Infections, Burkholderia cenocepacia, Persistent Infection. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cystic Fibrosis Foundation Therapeutics, Pharmaceutical Research and Manufacturers of America Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Burkholderia cenocepacia , a member of the Burkholderia cepacia complex (Bcc), causes severe, treatment-resistant lung infections in individuals with cystic fibrosis and chronic granulomatous disease. Hypothesis. We hypothesized that the C3HeB/FeJ mouse strain, characterized by impaired macrophage-mediated immunity, would be susceptible to persistent infection by clinical Bcc isolates.

Aim

To evaluate C3HeB/FeJ susceptibility to various Bcc isolates and characterize the macrophage-intrinsic responses and antibiotic susceptibility within this model. Methodology. C3HeB/FeJ and C57BL/6 mice were compared for susceptibility to pulmonary infection with B. cenocepacia AU0728 following intratracheal inoculation. Bacterial persistence and extrapulmonary dissemination were monitored for up to 42 days. Host immune responses were assessed through systemic leucocyte profiling and analysis of bone marrow–derived macrophage (BMDM) function, including intracellular bacterial control, cytokine production and time-resolved cell-death responses. Model breadth was evaluated using three additional clinical Bcc isolates. Finally, the in vivo efficacy of high-dose ceftazidime or meropenem was assessed against established pulmonary infection.

Results

C3HeB/FeJ mice sustained significantly higher pulmonary burdens of B. cenocepacia AU0728 than C57BL/6 mice, resulting in a stable, non-sterilizing infection with extrapulmonary dissemination lasting at least 42 days. In vitro , C3HeB/FeJ BMDMs supported higher intracellular bacterial loads and failed to mount effective IFN-γ–dependent intracellular control. Mixed-effects modelling of cell-death responses revealed that both strains initiated early apoptotic signalling following infection; however, this response was attenuated in C3HeB/FeJ macrophages and was not restored by IFN-γ pretreatment. In contrast, late-stage membrane permeabilization increased progressively over time and exhibited strain- and IFN-γ–dependent modulation at later stages of infection. Susceptibility was highly strain-specific: three additional clinical Bcc isolates were rapidly cleared from C3HeB/FeJ lungs. Treatment with ceftazidime or meropenem reduced established pulmonary bacterial burdens by ~1.4–1.5 log₁₀ c.f.u. but did not achieve sterilization.

Conclusion

These findings identify C3HeB/FeJ mice as a selectively susceptible host for sustained pulmonary infection by B. cenocepacia AU0728 and demonstrate that persistence in this model is strongly strain-dependent. Impaired macrophage-intrinsic IFN-γ–dependent control and stage-specific dysregulation of cell-death responses contribute to bacterial persistence. This immunocompetent mouse model provides a tractable platform for dissecting strain-level virulence mechanisms and for evaluating therapeutic strategies targeting chronic Bcc infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Burkholderia InfectionsBurkholderia cenocepaciaPersistent InfectionAnimalsMice, Inbred C57BLDisease Models, AnimalMiceMacrophagesAnti-Bacterial AgentsMice, Inbred C3HMeropenemCeftazidimeThienamycinsFemaleCytokinesLung

Stichwörter der Autor:innen

Burkholderia cenocepaciaC3HeB/FeJ miceantimicrobial resistancemacrophage activationpersistent pulmonary infectionstrain specificity

Substanzen

Anti-Bacterial AgentsMeropenemCeftazidimeThienamycinsCytokines

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Present address: Department of Integrative Biology, University of California, Berkeley, CA, 94720, USA.
  • Present address: Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, 55455, USA.
  • Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.

Förderung

  • Cystic Fibrosis Foundation Therapeutics
  • Pharmaceutical Research and Manufacturers of America Foundation

Zitieren

APA

Chen, Z., Romero-Gonzalez, M., Maser, A., Leng, R., Caverly, L. J., Hershenson, M., & Brunaugh, A. D. (2026). Strain-specific persistence of Burkholderia cenocepacia in the C3HeB/FeJ mouse model of pulmonary infection. Journal of Medical Microbiology, 75(4). https://doi.org/10.1099/jmm.0.002153

Vancouver

Chen Z, Romero-Gonzalez M, Maser A, Leng R, Caverly LJ, Hershenson M, et al. Strain-specific persistence of Burkholderia cenocepacia in the C3HeB/FeJ mouse model of pulmonary infection. Journal of Medical Microbiology. 2026;75(4). doi:10.1099/jmm.0.002153

BibTeX
@article{Chen2026,
  author = {Chen, Ziting and Romero-Gonzalez, Mariana and Maser, Andrea and Leng, Ruisi and Caverly, Lindsay J and Hershenson, Marc and Brunaugh, Ashlee D},
  title = {Strain-specific persistence of Burkholderia cenocepacia in the C3HeB/FeJ mouse model of pulmonary infection},
  journal = {Journal of Medical Microbiology},
  year = {2026},
  volume = {75},
  number = {4},
  doi = {10.1099/jmm.0.002153}
}
Kostenlos starten →